Erschienen in:
15.10.2021 | Editorial
Hughes-Stovin syndrome (HSS): current status and future perspectives
verfasst von:
Sebastian Sanduleanu, Tim L. T. A. Jansen
Erschienen in:
Clinical Rheumatology
|
Ausgabe 12/2021
Einloggen, um Zugang zu erhalten
Excerpt
In 1959, John Patterson Hughes and Peter George Ingle Stovin, two British physicians, described two male patients presenting with an undefined systemic illness characterized by severe recurrent hemoptysis due to deep venous thrombosis (DVT) and segmental pulmonary artery aneurysms (PAA) [
1]. At autopsy a rupture of the arterial aneurysms into the adjacent bronchi had occurred in both patients who died suffocating by massive hemoptysis [
1]. A similar description was given as early as 1912 by Beattie and Hall [
2]. In 1962, the first paper using the eponym “Hughes-Stovin syndrome” (HSS) was published [
3]. But what exactly is HSS? …